Scleromyxedema, a therapeutic dilemma

Scleromyxedema, a therapeutic dilemma

Scleromyxedema is characterized by indurated erythematous papules disseminated on the face, chest and limbs. About twenty cases treated with thalidomide, stem cells, melphalan and immunoglobulin with varying results have been described. We present the case of a 28-year-old male patient diagnosed wit...

Full description

Bibliographic Details
Main Authors: Julio Cesar Salas-Alanis, Brayant Martinez-Jaramillo, Minerva Gomez-Flores, Jorge Ocampo-Candiani
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2015-01-01
Series:Indian Journal of Dermatology
Subjects:
Papular mucinosis
scleromyxedema
thalidomide
treatment failure
UVA1
Online Access:http://www.e-ijd.org/article.asp?issn=0019-5154;year=2015;volume=60;issue=2;spage=215;epage=215;aulast=Salas-Alanis
Description
Summary:Scleromyxedema is characterized by indurated erythematous papules disseminated on the face, chest and limbs. About twenty cases treated with thalidomide, stem cells, melphalan and immunoglobulin with varying results have been described. We present the case of a 28-year-old male patient diagnosed with scleromyxedema not associated with monoclonal gammopathy, multi-treated with anti-leprosy drugs, UVA1, and thalidomide for 4 years with no improvement.
ISSN:0019-5154
1998-3611

Similar Items